SNY logo

Sanofi (SNY) Cash and cash equivalents

annual cash & cash equivalents:

$7.82B-$1.92B(-19.71%)
December 31, 2024

Summary

  • As of today (September 12, 2025), SNY annual cash & cash equivalents is $7.82 billion, with the most recent change of -$1.92 billion (-19.71%) on December 31, 2024.
  • During the last 3 years, SNY annual cash & cash equivalents has fallen by -$3.66 billion (-31.87%).
  • SNY annual cash & cash equivalents is now -54.04% below its all-time high of $17.03 billion, reached on December 31, 2020.

Performance

SNY Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSNYbalance sheet metrics

quarterly cash & cash equivalents:

N/A
September 30, 2022

Summary

  • SNY quarterly cash & cash equivalents is not available.

Performance

SNY quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherSNYbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

SNY Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.7%-
3 y3 years-31.9%-
5 y5 years-28.4%-

SNY Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-42.4%at low
5 y5-year-54.0%at low
alltimeall time-54.0%+667.5%

SNY Cash and cash equivalents History

DateAnnualQuarterly
Dec 2024
$7.82B(-19.7%)
-
Dec 2023
$9.75B(-28.3%)
-
Dec 2022
$13.59B(+18.4%)
-
Jun 2022
-
$6.90B(-22.7%)
Dec 2021
$11.48B(-32.6%)
-
Dec 2020
$17.03B(+55.7%)
-
Dec 2019
$10.94B(+38.1%)
-
Dec 2018
$7.92B(-36.1%)
-
Dec 2017
$12.39B(+13.1%)
-
Dec 2016
$10.95B(+9.0%)
-
Dec 2015
$10.04B(+9.8%)
-
Dec 2014
$9.15B(-21.4%)
$8.93B(-21.7%)
Dec 2013
$11.63B(+34.5%)
$11.40B(+112.8%)
Dec 2012
$8.65B(+55.0%)
-
Jun 2012
-
$5.36B(-43.4%)
Dec 2011
$5.58B(-36.2%)
-
Jun 2011
-
$9.47B(+10.1%)
Dec 2010
$8.74B(+22.6%)
$8.60B(+28.1%)
DateAnnualQuarterly
Dec 2009
$7.13B(+287.4%)
$6.71B(-23.1%)
Jun 2009
-
$8.72B(+47.7%)
Dec 2008
-
$5.91B(+296.1%)
Jun 2008
-
$1.49B(-40.3%)
Dec 2007
-
$2.50B(+70.4%)
Jun 2007
-
$1.47B(-3.7%)
Dec 2006
-
$1.52B(+2.5%)
Jun 2006
-
$1.48B(+0.5%)
Dec 2005
$1.84B(-45.6%)
$1.48B(-45.9%)
Jun 2005
-
$2.73B(+9.5%)
Dec 2004
$3.38B(-3.0%)
$2.49B(+1431.8%)
Jun 2004
-
$162.77M(-14.7%)
Dec 2003
$3.49B(+34.8%)
$190.88M(+53.7%)
Jun 2003
-
$124.16M(-17.7%)
Dec 2002
$2.59B(+149.1%)
$150.95M(-20.9%)
Jun 2002
-
$190.88M
Dec 1998
$1.04B(+1.8%)
-
Dec 1996
$1.02B
-

FAQ

  • What is Sanofi annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Sanofi?
  • What is Sanofi annual cash & cash equivalents year-on-year change?
  • What is the all time high quarterly cash & cash equivalents for Sanofi?

What is Sanofi annual cash & cash equivalents?

The current annual cash & cash equivalents of SNY is $7.82B

What is the all time high annual cash & cash equivalents for Sanofi?

Sanofi all-time high annual cash & cash equivalents is $17.03B

What is Sanofi annual cash & cash equivalents year-on-year change?

Over the past year, SNY annual cash & cash equivalents has changed by -$1.92B (-19.71%)

What is the all time high quarterly cash & cash equivalents for Sanofi?

Sanofi all-time high quarterly cash & cash equivalents is $11.40B
On this page